Paclitaxel Plus Cetuximab as Induction Chemotherapy for Patients With Locoregionally Advanced Head and Neck Squamous Cell Carcinoma Unfit for Cisplatin-Based Chemotherapy

ObjectivesInduction chemotherapy (ICT) followed by definitive treatment is an accepted non-surgical approach for locoregionally advanced head and neck squamous cell carcinoma (LA-HNSCC). However, ICT remains a challenge for cisplatin-unfit patients. We evaluated paclitaxel and cetuximab (P-C) as ICT...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Juan A. Marín-Jiménez, Marc Oliva, Paloma Peinado Martín, Santiago Cabezas-Camarero, Maria Plana Serrahima, Gonzalo Vázquez Masedo, Alicia Lozano Borbalas, María N. Cabrera Martín, Anna Esteve, María C. Iglesias Moreno, Esther Vilajosana Altamis, Lorena Arribas Hortigüela, Miren Taberna Sanz, Pedro Pérez-Segura, Ricard Mesía
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-07-01
Subjects:	Head and neck squamous cell carcinoma head and neck cancer induction chemotherapy paclitaxel cetuximab radiotherapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.953020/full